Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Let Us Save Lives
In published Phase 3 trials, mean weight loss for retatrutide at 80 weeks (28.3%) exceeded the mean for tirzepatide in SURMOUNT-1 at 72 weeks (22.5%)
Long time no see
This paradox occurs because the peptide triggers lasting changes in gene expression that continue independently after the peptide clears the system
US$ 24.16
US$ 23.30
US$ 22.95
US$ 25.22
US$ 27.63
US$ 20.56
